Literature DB >> 1611768

Treatment of congenital pseudoarthrosis of the tibia using the Ilizarov technique.

D Paley1, M Catagni, F Argnani, J Prevot, D Bell, P Armstrong.   

Abstract

The principle of treatment of congenital pseudoarthrosis of the tibia (CPT) with the Ilizarov method corrects all angular deformity and maximizes the cross-sectional area of union of the pseudoarthrosis. Fifteen patients with a total of 16 CPT were treated using the Ilizarov apparatus. Various forces were used to treat the pseudoarthrosis site including compression, distraction, open reduction, resection and shortening, resection and bone transport, and invagination of one end in the other. Lengthening was performed in 12 of the 16. Deformity was corrected in all cases. The union rate was 94% with one treatment and 100% with two treatments. There were five refractures, three early and two late. Previous pin sites, residual angular deformity, and natural history were considered predisposing factors for refractures. One patient refractured twice but remained ununited. Fifteen remained united, with a mean follow-up period of four years (range, two to seven). There were two residual deformities, one in the regenerate and one at the level of the CPT.

Entities:  

Mesh:

Year:  1992        PMID: 1611768

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  30 in total

1.  Periosteal grafting for congenital pseudarthrosis of the tibia: a preliminary report.

Authors:  Ahmed M Thabet; Dror Paley; Mehmet Kocaoglu; Levent Eralp; John E Herzenberg; Omer Naci Ergin
Journal:  Clin Orthop Relat Res       Date:  2008-10-25       Impact factor: 4.176

Review 2.  Treatment of critical-sized bone defects: clinical and tissue engineering perspectives.

Authors:  Erika Roddy; Malcolm R DeBaun; Adam Daoud-Gray; Yunzhi P Yang; Michael J Gardner
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-10-28

3.  Preliminary experience with the combined use of recombinant bone morphogenetic protein and bisphosphonates in the treatment of congenital pseudarthrosis of the tibia.

Authors:  Oliver Birke; Aaron Schindeler; Manoj Ramachandran; Chris T Cowell; Craig F Munns; Michael Bellemore; David G Little
Journal:  J Child Orthop       Date:  2010-10-21       Impact factor: 1.548

Review 4.  Ilizarov treatment of congenital pseudarthrosis of the tibia: a multi-targeted approach using the Ilizarov technique.

Authors:  In Ho Choi; Tae-Joon Cho; Hyuk Ju Moon
Journal:  Clin Orthop Surg       Date:  2011-02-15

5.  Relationship between postoperative complications and fibular integrity in congenital pseudarthrosis of the tibia in children.

Authors:  Yao-Xi Liu; Hai-Bo Mei; Guang-Hui Zhu; Rong-Guo He; Kun Liu; Jin Tang; Jiang-Yan Wu; Wei-Hua Ye; Xin Hu; Qian Tan; An Yan; Sheng-Xiang Huang; Xiao-Qian Tan; Ting Lei
Journal:  World J Pediatr       Date:  2016-12-23       Impact factor: 2.764

6.  Successful treatment of congenital pseudarthrosis of the tibia: still a challenge.

Authors:  K Bobotas; S N Lallos; V S Nikolaou; D S Kοrres; N E Efstathopoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-09-02

7.  Masquelet's procedure and bone morphogenetic protein in congenital pseudarthrosis of the tibia in children: a case series and meta-analysis.

Authors:  Bruno Dohin; Remi Kohler
Journal:  J Child Orthop       Date:  2012-07-21       Impact factor: 1.548

8.  Congenital pseudarthrosis of the tibia: the results of an evolving protocol of management.

Authors:  N Nicolaou; A Ghassemi; R A Hill
Journal:  J Child Orthop       Date:  2013-06-12       Impact factor: 1.548

9.  Induced membrane technique for the treatment of congenital pseudarthrosis of the tibia: preliminary results of five cases.

Authors:  Stéphanie Pannier; Zagorka Pejin; Caroline Dana; Alain Charles Masquelet; Christophe Glorion
Journal:  J Child Orthop       Date:  2013-10-08       Impact factor: 1.548

10.  Epidemiology and treatment outcome of congenital pseudarthrosis of the tibia.

Authors:  Joachim Horn; Harald Steen; Terje Terjesen
Journal:  J Child Orthop       Date:  2013-01-18       Impact factor: 1.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.